Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

Overview of attention for article published in Annals of Surgical Oncology, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet

policy: 1 policy source

Citations

dimensions_citation: 219 Dimensions

Readers on

mendeley: 134 Mendeley

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer: Committee papers

Cited by National Institute for Health and Care Excellence on 20 May 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.